Schrodinger, Inc. financial data

Symbol
SDGR on Nasdaq
Industry
Pharmaceutical Preparations
Location
1540 Broadway, 24 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 436 % -15%
Debt-to-equity 46 % +7.06%
Return On Equity -35.8 % -548%
Return On Assets -24.5 % -539%
Operating Margin -113 % -27.6%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 63M shares +1.31%
Entity Public Float 1.76B USD +36.5%
Weighted Average Number of Shares Outstanding, Basic 72.8M shares +1.24%
Weighted Average Number of Shares Outstanding, Diluted 72.8M shares +1.24%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 193M USD -3.03%
Cost of Revenue 67.8M USD -12.5%
Research and Development Expense 204M USD +23.7%
Selling and Marketing Expense 40.2M USD +9.56%
General and Administrative Expense 99.6M USD +3%
Operating Income (Loss) -218M USD -23.7%
Nonoperating Income (Expense) 40.2M USD -82%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -178M USD -478%
Income Tax Expense (Benefit) -393K USD -114%
Net Income (Loss) Attributable to Parent -178M USD -502%
Earnings Per Share, Basic -2.46 USD/shares -497%
Earnings Per Share, Diluted -2.43 USD/shares -534%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 160M USD -35.7%
Marketable Securities, Current 228M USD -7.55%
Accounts Receivable, after Allowance for Credit Loss, Current 13.3M USD -33.2%
Assets, Current 456M USD -16.7%
Property, Plant and Equipment, Net 22.5M USD +63.6%
Operating Lease, Right-of-Use Asset 113M USD -5.85%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 4.79M USD 0%
Other Assets, Noncurrent 5.15M USD -30.5%
Assets 669M USD -15.7%
Accounts Payable, Current 11.2M USD +8.65%
Contract with Customer, Liability, Current 41.8M USD
Liabilities, Current 111M USD +5.79%
Contract with Customer, Liability, Noncurrent 5.2M USD
Operating Lease, Liability, Noncurrent 103M USD -8.4%
Other Liabilities, Noncurrent 297K USD -58%
Liabilities 220M USD -4.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax 597K USD
Retained Earnings (Accumulated Deficit) -485M USD -57.7%
Stockholders' Equity Attributable to Parent 449M USD -20.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 449M USD -20.3%
Liabilities and Equity 669M USD -15.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.3M USD -26.3%
Net Cash Provided by (Used in) Financing Activities 8.01M USD +823%
Net Cash Provided by (Used in) Investing Activities 5.08M USD -97.1%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 63M shares +1.31%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 170M USD -33.4%
Deferred Tax Assets, Valuation Allowance 136M USD -1.4%
Deferred Tax Assets, Gross 189M USD +10.6%
Operating Lease, Liability 121M USD +27.2%
Payments to Acquire Property, Plant, and Equipment 4.1M USD +14.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -176M USD -473%
Lessee, Operating Lease, Liability, to be Paid 189M USD +26.1%
Property, Plant and Equipment, Gross 28.4M USD +26.7%
Operating Lease, Liability, Current 16.9M USD +3.74%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.1M USD +42.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.9M USD +50.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68M USD +24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.8M USD +43.6%
Deferred Tax Assets, Operating Loss Carryforwards 44.1M USD -34.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.67M USD +38%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.7M USD +38.7%
Operating Lease, Payments 7.53M USD +156%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.44M USD -18.4%
Deferred Tax Assets, Net of Valuation Allowance 52.7M USD +61.5%
Share-based Payment Arrangement, Expense 50M USD +9.77%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%